A novel BCR-ABL1 fusion gene with genetic heterogeneity indicates a good prognosis in a chronic myeloid leukemia case

BACKGROUND: Chronic myelogenous leukemia (CML) is a pluripotent hematopoietic stem cell disorder caused by the fusion of the BCR and ABL1 genes. Quantitative RT-PCR (qRT-PCR) is a routinely performed screening technique to identify BCR-ABL1 fusion genes, but a limitation of this method is its inabil...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Fen, Jin, Runming, Hu, Yu, Mei, Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438485/
https://www.ncbi.nlm.nih.gov/pubmed/28533818
http://dx.doi.org/10.1186/s13039-017-0322-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438485/
https://www.ncbi.nlm.nih.gov/pubmed/28533818
http://dx.doi.org/10.1186/s13039-017-0322-8

Ejemplares similares